Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Bio Technology General - BTGC -- Ignore unavailable to you. Want to Upgrade?

To: Jim Oravetz who wrote (1831)	4/29/1999 1:06:00 PM
From: Jim Oravetz	Read Replies (1) \| Respond to of 2028

Bio-Tech Genl Names Virgil Thompson Pres, Oper Chief Dow Jones Newswires ISELIN, N.J. -- Bio-Technology General Corp. (BTGC) named Virgil Thompson president and chief operating officer, succeeding Sim Fass, chairman and chief executive. In a press release Thursday, Bio-Technology said Thompson was Cytel Corp.'s (CYTL) president and chief executive. Bio-Technology also named Eli Admoni president of Bio-Technology General (Israel) Ltd., and senior vice president of the corporation. Admoni is also succeeding Fass, who held both positions. Admoni was president and chief executive of Israel Can Co. In a separate release, Cytel said Robert Roe, a director, will act as president until until the company completes its transition to researching vaccine development. Cytel also plans to change its name to Epimmune, one of its units. Bio-Technology is a biopharmaceutical company. Cytel Corp. discovers, designs and develops new drugs for the effective treatment of acute and chronic inflammatory diseases, infectious diseases and cancer. Revenues for the 9 months ended 9/98 decreased 29% to $2.8M. Net loss increased 33% to $13.8M. Revenues reflect the absense of research and development revenue from agreements with Searle, Nextran & Abbott. Higher loss reflects increased clinical trial costs. Address: 9393 Towne Centre Drive San Diego, CA 92121 Phone: (619) 450-7100 Web Site: cytelcorp.com Chmn.: Howard E. Greene Jr. Pres./CEO: Virgil D. Thompson VP-Fin./CFO: Edward C. Hall Exec.VP/COO.: Robert L. Roe Employees: 90 Fiscal Year: 1997 Fiscal Year Ending Date: 12/31/1997 Sales ($ millions): 5.1 1-Yr. Sales Change: -53.6% Institutional Held: 18.6% Number of Institutional Shareholders: 19 Ticker Symbol: CYTL Exchange: Nasdaq ++++ Looks like Sim is only chairman now. Let's hope that shareholders will be rewarded down the road. Long BTGC Jim